Antidiabetic agents and cardiovascular risk in type 2 diabetes

被引：0

作者：

Stuart W. Zarich

机构：

[1] Bridgeport Hospital,Division of Cardiovascular Medicine

来源：

Nature Reviews Endocrinology | 2009年 / 5卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Currently, controversy reigns over the effects of different antidiabetic agents on cardiovascular outcomes in type 2 diabetes mellitus (T2DM). This article reviews the findings of recent cardiovascular outcome trials that assessed the safety of various glucose-lowering strategies. Multifactorial interventions to improve glycemic control, hypertension, and dyslipidemia enhance survival and reduce macrovascular events in T2DM. Insulin-sensitization regimens may be preferred in patients with T2DM who have coronary disease.

引用

页码：500 / 506

页数：6

共 50 条

[1] Antidiabetic agents and cardiovascular risk in type 2 diabetes
Zarich, Stuart W.
NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (09) : 500 - 506
[2] Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes
Macfarlane, D. P.
Paterson, K. R.
Fisher, M.
DIABETES OBESITY & METABOLISM, 2008, 10 (07): : 533 - 544
[3] Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes
Holstein, A
Egberts, EH
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2003, 111 (07) : 405 - 414
[4] Type 2 diabetes and factors of cardiovascular risk in the antidiabetic center of Abidjan
Acka, K. F.
Ekou, F. K.
Akpess, A.
Konan, P. A.
Manouan, M.
Kouame, S.
Koffi, K. S.
Kouakou, T.
Kouakou, E.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 : S48 - S49
[5] Oral antidiabetic agents in type 2 diabetes
Levetan, Claresa
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) : 945 - 952
[6] Metabolic profile and cardiovascular risk in patients with Type 2 diabetes not controlled with oral antidiabetic agents: Post-Adelante study
Calderon, A.
Sarasa, P.
Barrios, V.
DIABETIC MEDICINE, 2008, 25
[7] Fracture Risk of Antidiabetic Agents in Type 2 Diabetes-A Network Meta-analysis
Tsai, Wen Hsuan
Kong, Siang Ke
Tsai, Ming-Chieh
DIABETES, 2022, 71
[8] IMPACT OF ANTIDIABETIC THERAPY ON THE RISK OF CARDIOVASCULAR DISEASES AND THEIR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Ametov, A. S.
Pyanykh, O. P.
Chernikova, N. A.
TERAPEVTICHESKII ARKHIV, 2010, 82 (08) : 71 - 75
[9] Manage cardiovascular risk in patients with type 2 diabetes by using agents with proven cardiovascular benefits
Writers, Adis Medical
DRUGS & THERAPY PERSPECTIVES, 2020, 36 (05) : 181 - 185
[10] Manage cardiovascular risk in patients with type 2 diabetes by using agents with proven cardiovascular benefits
Drugs & Therapy Perspectives, 2020, 36 : 181 - 185

← 1 2 3 4 5 →